Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents

Japanese Journal of Veterinary Research

Volumn 52, Issue 3, 2004, Pages 105-112

  Kariwa, Hiroaki ^a   Fujii, Nobuhiro ^b   Takashima, Ikuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronavirus; Disinfection; Inactivation; Infection control; Povidone iodine; SARS; Severe acute respiratory syndrome

Indexed keywords

ACETONE; ALCOHOL; FORMALDEHYDE; GLUTARALDEHYDE; ISODINE GARGLE; ISODINE NODO FRESH; ISODINE PALM; ISODINE SCRUB; METHANOL; POVIDONE IODINE;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISINFECTION; DRUG EFFICACY; EPIDEMIC; HEATING; INFECTION CONTROL; NONHUMAN; PRACTICE GUIDELINE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TEMPERATURE; TIME; ULTRAVIOLET RADIATION; VERO CELL; VIRUS INACTIVATION; VIRUS INFECTIVITY;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CERCOPITHECUS AETHIOPS; DISINFECTION; ETHANOL; FIXATIVES; HEAT; INFECTION CONTROL; POVIDONE-IODINE; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; ULTRAVIOLET RAYS; VERO CELLS; VIRUS INACTIVATION;

ANIMALIA; CORONAVIRUS; SARS CORONAVIRUS; SARS COV;

EID: 11044225202     PISSN: 00471917     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chan, K. H., Poon, L. L., Cheng, V. C., Guan, Y., Hung, I. F., Kong, J., Yam, L. Y., Seto, W. H., Yuen, K. Y., Peiris, J. S. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis., 10: 294-299.
2. Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., Berger, A., Burguiere, A. M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J. C., Muller, S., Rickerts, V., Sturmer, M., Vieth, S., Klenk, H. D., Osterhaus, A. D., Schmitz, H., Doerr, H. W. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med., 348:1967-1976.
3. Duan, S. M., Zhao, X. S., Wen, R. F., Huang, J. J., Pi, G. H., Zhang, S. X., Han, J., Bi, S. L., Ruan, L., Dong, X. P., SARS Research Team. 2003. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed. Environ. Sci., 16:246-255.
4. Guan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., Butt, K. M., Wong, K. L., Chan, K. W., Lim, W., Shortridge, K. F., Yuen, K. Y., Peiris, J. S., Poon, L. L. 2003. Isolation and characterization of viruses related to the SARS, coronavirus from animals in southern China. Science, 302:276-278.
5. Haley, C. E., Marling-Cason, M., Smith, J. W., Luby, J. P., Mackowiak, P. A. 1985. Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol., 21:991-992.
6. Kawana, R., Kitamura, T., Nakagomi, O., Matsumoto, I., Arita, M., Yoshihara, N., Yanagi, K., Yamada, A., Morita, O., Yoshida, Y., Furuya, Y., Chiba, S. 1997. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology, 195 Suppl. 2:29-35.
7. Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A. E., Humphrey, C. D., Shieh, W. J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., DeRisi, J., Yang, J. Y., Cox, N., Hughes, J. M., LeDuc, J. W., Bellini, W. J., Anderson, L. J., SARS Working Group. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med., 348: 1953-1966.
8. Peiris, J. S., Lai, S. T., Poon, L. L., Guan, Y., Yam, L. Y., Lim, W., Nicholls, J., Yee, W. K., Yan, W. W., Cheung, M. T., Cheng, V. C., Chan, K. H., Tsang, D. N., Yung, R. W., Ng, T. K., Yuen, K. Y., SARS study group. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 361: 1319-1325.
9. Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., Chan, A. K., Skowronski, D. M., Salit, I,, Simor, A. E., Slutsky, A. S., Doyle, P. W., Krajden, M., Petric, M., Brunham, R. C., McGeer, A. J., National Microbiology Laboratory, Canada, Canadian Severe Acute Respiratory Syndrome Study Team. 2003. Identification of Severe Acute Respiratory Syndrome in Canada. N. Engl. J. Med., 348:1995-2005.
10. Rabenau, H. F., Cinatl, J., Morgenstern, B., Bauer, G., Preiser, W., Doerr, H. W. 2004. Stability and inactivation of SARS coronavirus. Med. Microbiol. Immunol (Berl). (from E-publishing).
11. Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Penaranda, S., Bankamp, B., Maher, K., Chen, M. H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J. L., Chen, Q., Wang, D., Erdman, D. D., Peret, T. C., Burns, C., Ksiazek, T. G., Rollin, P. E., Sanchez, A., Liffick, S., Holloway, B., Limor, J., McCaustland, K., Olsen-Rasmussen, M., Fouchier, R., Gunther, S., Osterhaus, A. D., Drosten, C., Pallansch, M. A., Anderson, L. J., Bellini, W. J. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300:1394-1399.
12. Shiraishi, T., Nakagawa, Y. 2002. Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations. Dermatology, 204 Suppl. 1:37-41.
13. World Health Organization. 2003. Acute respiratory syndrome, China. Wkly. Epidemiol. Rec., 78:41.
14. World Health Organization. 2003. Acute respiratory syndrome China, Hong Kong Special Administrative Region of China, and Viet Nam. China. Wkly. Epidemiol. Rec., 78:73-74.
15. World Health Organization. 2003. Severe acute respiratory syndrome (SARS) Wkly. Epidemiol. Rec., 78:181-183.
16. World Health Organization. 2003. Severe acute respiratory syndrome (SARS): over 100 days into the outbreak. Wkly. Epidemiol. Rec., 78:217-220.
17. World Health Organization. 2003. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. Available from URL: http://www.who.int/csr/sars/survival2003_05_04/en/index.html
18. World Health Organization. 2003. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available from URL: http://www.who.int/csr/sars/country/table2003_09_23/en/
19. World Health Organization. 2003. Severe acute respiratory syndrome (SARS) in Singapore. 2003 September. Available from URL: http://www.who.int/csr/don/2003_09_10/en/
20. World Health Organization. Confirmed SARS case in research laboratory in Taiwan. 2003 December. Available from URL: http://www.who.int/csr/sars/docs/pressreleases/tw_17122003.asp
21. World Health Organization. Update 4: Review of probable and laboratory-confirmed SARS cases in southern China. Available from URL: http://www.who.int/csr/don/2004_01_27/en/
22. Taguchi, F., Riku, S., Shimizu, M. 2003. Antiviral activity of povidone iodine products to murine coronavirus. Jpn. J. Chemotherapy, 51: 583-584. In Japanese.
23. Yu, I. T., Li, Y., Wong, T. W., Tam, W., Chan, A. T., Lee, J. H., Leung, D. Y., Ho, T. 2004. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med., 350:1731-1739.
24. Yam WC, Chan KH, Poon LL, Guan Y, Yuen K-Y, Seto WH, et al. 2003. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol., 41:4521-4524.